BIO-TECHNE Corp — Director's Dealing 2022

Sep 29, 2022

SEC Form 4/A — Form 4/A

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2022-02-01

Reporting Person: Geist William (President, Protein Sciences)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-01	Restricted Stock Units	$	A	2490	Acquired		Common Stock (2490)	Direct

Footnotes

F1: This amendment is being filed solely to move this grant of restricted stock units from Table I (where it was originally reported) to Table II.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F3: Represents 2,490 shares of restricted stock for which the risk of forfeiture will lapse as to 830 shares on each of February 1, 2023, February 1, 2024 and February 1, 2025.